CYP19A1 and endometriosis: Therefore, along with the anti-inflammatory treatments described above, current endometriosis treatments involve suppressing E2 levels through gonadotropin-releasing hormone agonists, oral contraceptives, synthetic progestins, and aromatase inhibitors [6].